The 4 top performers
| # | Fund | 30 days | Net assets | Cost | Yield | 1 mo | YTD | 1 yr | 3 yr | 5 yr |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IDNA iShares Genomics Immunology and Healthcare ETF | $190.9M | 0.47% | 0.69% | +0.6% | +61.1% | +66.9% | +35.8% | -2.1% | |
| 2 | ARKG ARK Genomic Revolution ETF | $1.56B | 0.75% | 0% | -3.2% | +78.3% | +65.8% | +32.4% | -6.8% | |
| 3 | GNOM Global X Genomics & Biotechnology ETF | $55.8M | 0.5% | 0.94% | -2.0% | +51.5% | +56.6% | +25.8% | -3.9% | |
| 4 | HELX Franklin Genomic Advancements ETF | $27.9M | 0.5% | 0.32% | 0.0% | +22.0% | +28.8% | +20.4% | -3.0% |
Funds with less than $25 million in net assets and leveraged or inverse funds are left out of the ranking. Returns are total returns with distributions reinvested (3 and 5 years annualized), as of Oct 27, 2026.
How the top 4 compare
Growth of each fund’s value from the start of the range, distributions reinvested. The dashed gray line is the S&P 500 (SPY).
All 4 Genomics & Genetic Research ETFs
Largest first. Click a heading to sort.
| Fund | Issuer | Net assets | Cost | Yield | YTD | 1 yr | 5 yr |
|---|---|---|---|---|---|---|---|
| ARKG ARK Genomic Revolution ETF | ARK Invest | $1.56B | 0.75% | 0% | +78.3% | +65.8% | -6.8% |
| IDNA iShares Genomics Immunology and Healthcare ETF | iShares | $190.9M | 0.47% | 0.69% | +61.1% | +66.9% | -2.1% |
| GNOM Global X Genomics & Biotechnology ETF | Global X | $55.8M | 0.5% | 0.94% | +51.5% | +56.6% | -3.9% |
| HELX Franklin Genomic Advancements ETF | Franklin Templeton | $27.9M | 0.5% | 0.32% | +22.0% | +28.8% | -3.0% |
Picking funds is the easy part
ReadyAimRetire shows whether your whole plan works, with your accounts, Social Security, taxes and spending, year by year.